Kiniksa Pharmaceuticals International, Plc · NASDAQ:KNSA
Patel Sanj K sold 7,278 Kiniksa Pharmaceuticals International, Plc shares (Form 4)
Traded Apr 6 to Apr 7, 2026 · Filed Apr 8, 2026
From Apr 6 to Apr 7, 2026, Patel Sanj K (Director, CHAIRMAN & CEO) sold 7,278 Kiniksa Pharmaceuticals International, Plc shares at US$50.01 for US$364K under a trading plan, leaving 76,174 shares. Filed Apr 8, 2026 (Form 4).
- Sold
- 7,278 shares
- Price
- US$50.01
- Value
- US$364K
- Holding after
- 76,174 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, CHAIRMAN & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 6, 2026 | Class A Ordinary Share | Option exercise | 7,278 | US$10.36 | 7,278 | Direct |
| Apr 6, 2026 | Class A Ordinary Share | Sale | 7,278 | US$50.01 | 0 | Direct |
| Apr 7, 2026 | Class A Ordinary Share | Option exercise | 9,991 | 81,005 | Indirect | |
| Apr 7, 2026 | Class A Ordinary Share | Shares withheld for tax | 4,831 | US$48.94 | 76,174 | Indirect |
Source
Related
- Kiniksa Pharmaceuticals International, Plc
- Patel Sanj K
- Kiniksa Pharmaceuticals International, Plc shareholders
- Form 4 · Patel Sanj K · Sep 3, 2026
- Form 4 · Patel Sanj K · Jun 2, 2026
- Form 4 · Patel Sanj K · May 1, 2026
- Form 4 · Patel Sanj K · Apr 30, 2026
- Form 4 · Patel Sanj K · Apr 3, 2026
- Form 4 · Megna Michael R · Sep 3, 2026
- Form 4 · Paolini John F. · Sep 3, 2026
- Form 4 · Ragosa Mark · Sep 3, 2026
- Form 4 · Moat Ross · Sep 3, 2026
- Form 4 · Quart Barry D · Aug 21, 2026